0001382963-16-000250.txt : 20161025
0001382963-16-000250.hdr.sgml : 20161025
20161025215258
ACCESSION NUMBER: 0001382963-16-000250
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161025
FILED AS OF DATE: 20161025
DATE AS OF CHANGE: 20161025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RITTER PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001460702
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263474527
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1880 CENTURY PARK EAST, SUITE 1000
CITY: LOS ANGELES
STATE: CA
ZIP: 90067
BUSINESS PHONE: 310-203-1000
MAIL ADDRESS:
STREET 1: 1880 CENTURY PARK EAST, SUITE 1000
CITY: LOS ANGELES
STATE: CA
ZIP: 90067
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ritter Ira E.
CENTRAL INDEX KEY: 0001631674
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37428
FILM NUMBER: 161951402
MAIL ADDRESS:
STREET 1: C/O RITTER PHARMACEUTICALS INC.
STREET 2: 1801 CENTURY PARK EAST, SUITE 1820
CITY: LOS ANGELES
STATE: CA
ZIP: 90096
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2016-10-25
0001460702
RITTER PHARMACEUTICALS INC
RTTR
0001631674
Ritter Ira E.
RITTER PHARMACEUTICALS, INC.
1880 CENTURY PARK EAST, #1000
LOS ANGELES
CA
90067
1
1
1
0
Exec. Chairman, CSO
Non-qualified Stock Option (Right to Buy)
2.60
2016-10-25
4
A
0
140044
0
A
2026-10-25
Common Stock
140044
140044
D
The option vests ratably over 48 months following the public disclosure of top-line data results from the Issuer's Phase 2b/2 clinical trial.
/s/Andrew J. Ritter, attorney-in-fact
2016-10-25